Podcast
Questions and Answers
Which treatment option will this patient receive before surgery?
Which treatment option will this patient receive before surgery?
- TCH+P x 6 cycles (correct)
- AI (+/- CDK 4/6 inhibitor)
- Endo Rx < 1 yr
- Neulasta for neutropenia
What is the prognosis for this patient with stage II disease?
What is the prognosis for this patient with stage II disease?
- 25%
- 15% - 25%
- 23%
- 85% (correct)
What is the general approach for a breast cancer patient with metastatic disease?
What is the general approach for a breast cancer patient with metastatic disease?
- Chemotherapy for HER2-
- Trastuzumab + pertuzumab + taxane (correct)
- Ovarian ablation + SERM + HER2 target Rx + Taxane
- Endocrine therapy for <1 year
What type of breast cancer is this patient diagnosed with?
What type of breast cancer is this patient diagnosed with?
Which treatment is indicated for HER2+ metastatic breast cancer patients who have previously received trastuzumab and/or a taxane?
Which treatment is indicated for HER2+ metastatic breast cancer patients who have previously received trastuzumab and/or a taxane?
Which therapy is a dual EGFR and ErbB2 inhibitor?
Which therapy is a dual EGFR and ErbB2 inhibitor?
Which treatment is a HER2-targeted antibody and microtubule inhibitor conjugate?
Which treatment is a HER2-targeted antibody and microtubule inhibitor conjugate?
Which treatment is recommended for ER-/PR-/HER2(Triple Negative) Breast Cancer?
Which treatment is recommended for ER-/PR-/HER2(Triple Negative) Breast Cancer?
Which is the most common cause of cancer death in women?
Which is the most common cause of cancer death in women?
Which stage of breast cancer involves tumor size greater than 5 cm?
Which stage of breast cancer involves tumor size greater than 5 cm?
What is the molecular subtype of breast cancer characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2)?
What is the molecular subtype of breast cancer characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2)?
Which stage of breast cancer involves tumor size greater than 5 cm?
Which stage of breast cancer involves tumor size greater than 5 cm?
What is the molecular subtype of breast cancer characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2)?
What is the molecular subtype of breast cancer characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2)?
What is the most common cause of cancer death in women?
What is the most common cause of cancer death in women?
Which is the recommended treatment for a pre-menopausal patient with stage II breast cancer, ER-negative, HER2-positive, and invasive ductal carcinoma?
Which is the recommended treatment for a pre-menopausal patient with stage II breast cancer, ER-negative, HER2-positive, and invasive ductal carcinoma?
What is the most common side effect of olaparib (Lynparza) in patients with metastatic breast cancer?
What is the most common side effect of olaparib (Lynparza) in patients with metastatic breast cancer?
What is the estimated overall survival rate for patients with metastatic breast cancer?
What is the estimated overall survival rate for patients with metastatic breast cancer?
Which treatment option is recommended for patients with recurrent or stage IV ER+/HER2+ breast cancer who have been on endocrine therapy for less than 1 year?
Which treatment option is recommended for patients with recurrent or stage IV ER+/HER2+ breast cancer who have been on endocrine therapy for less than 1 year?
Which treatment is indicated as adjuvant therapy or metastatic HER2+ breast cancer, where trastuzumab has failed or is contraindicated?
Which treatment is indicated as adjuvant therapy or metastatic HER2+ breast cancer, where trastuzumab has failed or is contraindicated?
Which treatment is a competitive ATP inhibitor (small molecule kinase inhibitor) that inhibits both EGFR and ErbB2 (HER2)?
Which treatment is a competitive ATP inhibitor (small molecule kinase inhibitor) that inhibits both EGFR and ErbB2 (HER2)?
Which treatment is a HER2-targeted antibody and microtubule inhibitor conjugate, with trastuzumab directing the chemotherapy preferentially to tumor cells?
Which treatment is a HER2-targeted antibody and microtubule inhibitor conjugate, with trastuzumab directing the chemotherapy preferentially to tumor cells?
Which treatment is a poly (ADP-ribose) polymerase (PARP) inhibitor that is recommended to test for BRCA status and PDL1 expression in triple-negative breast cancer?
Which treatment is a poly (ADP-ribose) polymerase (PARP) inhibitor that is recommended to test for BRCA status and PDL1 expression in triple-negative breast cancer?
